Clinical Trial Detail

NCT ID NCT04296578
Title Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone
Recruitment Not yet recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Stanford University
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone + Sodium Selenite

Age Groups: adult senior

No variant requirements are available.